Chief Medical Officer, Pelage Pharmaceuticals
Dr. Christina Weng is Chief Medical Officer of Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company developing first-in-class treatments for hair loss. She is a physician-scientist, entrepreneur, and board-certified dermatologist with a faculty appointment at Harvard Medical School.
At Pelage, Dr. Weng leads clinical development and provides strategic leadership across R&D and corporate strategy. She is advancing the clinical development of PP405, a first-in-class regenerative therapy for androgenetic alopecia (pattern hair loss) designed to reactivate dormant hair follicle stem cells and restore the body’s natural ability to grow hair.
Dr. Weng is also an attending dermatologist at the Massachusetts General Hospital. She serves on the Board of Directors for the Dermatology Innovation Forum and Dermatology Summit. She earned her undergraduate degree from the California Institute of Technology and her medical degree from Harvard Medical School and completed her dermatology residency and fellowship at Harvard.
Follow her on LinkedIn.